Vera Therapeutics, Inc. (VERA)
NASDAQ: VERA · Real-Time Price · USD
45.36
+1.54 (3.51%)
Nov 4, 2024, 12:59 PM EST - Market open
Vera Therapeutics Employees
Vera Therapeutics had 51 employees as of December 31, 2023. The number of employees increased by 5 or 10.87% compared to the previous year.
Employees
51
Change (1Y)
5
Growth (1Y)
10.87%
Revenue / Employee
n/a
Profits / Employee
-$2,114,706
Market Cap
2.47B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 51 | 5 | 10.87% |
Dec 31, 2022 | 46 | 29 | 170.59% |
Dec 31, 2021 | 17 | 9 | 112.50% |
Dec 31, 2020 | 8 | - | - |
Related Stocks
Company Name | Employees |
---|---|
iRhythm Technologies | 2,000 |
Twist Bioscience | 919 |
GoodRx Holdings | 694 |
ACADIA Pharmaceuticals | 598 |
Arrowhead Pharmaceuticals | 525 |
SpringWorks Therapeutics | 305 |
IDEAYA Biosciences | 124 |
Structure Therapeutics | 93 |
VERA News
- 5 days ago - Vera Therapeutics Announces Pricing of Public Offering of Class A Common Stock - GlobeNewsWire
- 6 days ago - Vera Therapeutics Announces Proposed Public Offering of Class A Common Stock - GlobeNewsWire
- 7 days ago - Vera Therapeutics' Atacicept Shows Sustained, Substantial Improvement In Kidney Function For Patients At Almost Two Years - Benzinga
- 8 days ago - Vera Therapeutics Announces 96-week eGFR Stabilization in ORIGIN Phase 2b Study of Atacicept in IgAN in a Late-Breaking Oral Presentation at the American Society of Nephrology Kidney Week 2024 - GlobeNewsWire
- 4 weeks ago - Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 4 weeks ago - Vera: Potential First Of Atacicept As A B-Cell Modulator For IgAN Patients - Seeking Alpha
- 4 weeks ago - Vera Therapeutics Announces Expanded Atacicept Development Program In Multiple Autoimmune Kidney Diseases - GlobeNewsWire
- 4 weeks ago - Vera Therapeutics Announces Late-Breaking Oral Presentation of ORIGIN Phase 2b Long-term Results at the American Society of Nephrology Kidney Week 2024 - GlobeNewsWire